Figure 6.
HbA1c (%) in 156 obese hypogonadal men with type 2 diabetes treated with testosterone undecanoate injections for up to 6 years.
HbA1c (%) in 156 obese hypogonadal men with type 2 diabetes treated with testosterone undecanoate injections for up to 6 years.